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Epidemiological Bases forthe Current
Ambient Carbon Monoxide Stndards
by Lewis H. Kuller* and Edward P. Radford*
Carbon monoxide is widely distributed in the environment, and acute or chronic toxic
effectsmaybe ofconsiderable public healthsignificance. A review ofthe basisforcurrent
ambient standards is given. Mortality and morbidity studies have been negative or
equivocal in relating carbon monoxide levels to health effects, but studies in human
subjects with compromised coronary or peripheral circulation support an effect ofacute
exposure to CO at blood levels equivalent to about 20 ppm over several hours. It is
possible that some of the cardiovascular effects of smoking may be related to the high
levels ofCO in cigarette smoke, but it has been difficult to isolate the contribution of CO
independent ofthe effects ofother smoke constituents.
Introduction
The relationship between carbon monoxide ex-
posure and health has been extensively reviewed.
The Committee on Medical and Biological Effects
of Environmental Pollution of the National Aca-
demy of Sciences issued a report in 1977 (1). A
workshop on carbon monoxide and cardiovascular
disease was held in Berlin, Germany, October
1978 and the proceedings subsequently published
(2). This report will be primarily concerned with
the evidence related to the ambient carbon mon-
oxide standard with particular emphasis on the
information available since 1978.
The current ambient carbon monoxide stan-
dard is an 8-hr annual average, maximum of 9
ppm and a maximum 1-hr level of 35 ppm not to
be exceeded more than once a year (Table 1) (3).
The occupational standard is higher and is aimed
at keeping the carboxyhemoglobin levels in the
blood below 5% (4).
The ambient standard was based on the effects
ofelevated carboxyhemoglobin levels on the car-
diovascular system and behavioral responses, es-
pecially vigilance tasks, in which the individual
was asked to report the occurrence of occasional
signals over long periods (1). The physiological
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Table 1. Air quality standards for carbon monoxide.a
co,
ppm
Primary 1 hr annual maximumb 35
Secondary 8 hr annual maximum 9
aU.S. EPA standard (3).
bNot to be exceeded more than once per year.
bases of carbon monoxide cardiovascular effects
and behavioral changes have been extensively
reviewed (1).
The physical properties ofcarbonmonoxide and
the methods ofconversion between various envi-
ronmental measures of carbon monoxide are
shown in Table 2. Ambient carbon monoxide lev-
els are sometimes reported as parts per million
(ppm) and/or as milligrams per cubic meter (mg/
m3) (5).
The occupational standard proscribes exposure
by any worker to a concentration greater than 35
ppm determined as a time-weighted average ex-
posure for an 8-hr work day. No level of carbon
monoxide to which workers are exposed can ex-
ceed a ceiling concentration of200 ppm. Workers
with overt cardiovascular disease may not be
protected at 35 ppm and should be included in a
medical program of preplacement and periodic
examinations. Such a medical program could also
provide the opportunity for conducting antismok-KULLER AND RADFORD
ing programs for high-risk employees. WHO and
NIOSH recommend that the maximal allowable
carboxyhemoglobin blood level not exceed 5%.
The relationship between environmental car-
bon monoxide exposure and blood carboxyhemo-
globin levels is primarily related to the concen-
tration of carbon monoxide in expired air, the
duration of exposure and respiratory ventilation
(Table 3). The alveolar carbon monoxide levels
can be crudely converted to carboxyhemoglobin
by dividing the carbon monoxide in ambient air
in ppm by 7. The half-life of carboxyhemoglobin
in the blood is about 4 hr.
The major source of carbon monoxide is ciga-
rette smoking. The other key sources are trans-
portation, industry and home heating. The rela-
tionship between cigarette smoking and expired
air carbon monoxide levels and carboxyhemoglo-
bin levels in the blood are well known. Expired
air carbon monoxide or carboxyhemoglobin is of-
ten used as an indicator for cigarette smoking
dose. Cigarette smoking exposes the pulmonary
capillary bed to about 400 ppm ofcarbon monox-
Table 2. Physical properties ofcarbon monoxide.a
Property Value
Molecular weight 28.01
Melting point -2070C
Boiling point - 1920C
Specific gravity relative to air 0.968
Density
At 0°C, 760 mm Hg 1.25 g/L
At 250C, 760 mm Hg 1.15 g/L
Explosive limits in air 12.5 to 74.2% (volume)
Solubilityb
At 0°C 3.54 mL/100 mL water
At 250C 2.14 mL/100 mL water
Conversion factors
At 0°C, 760 mm Hg 1 mg/m3 = 0.800 ppm
1 ppm = 1.250 mg/m3
At 250C, 760 mm Hg 1 mg/m3 = 0.874 ppm
1 ppm = 1.145 mg/m3
aData from US PHEW (5).
bVolume ofCO indicated is at0°C, 760 mm Hg.
Table 3. Relationship between carboxyhemoglobin and
alveolar carbon monoxide.
COHB% = 0.14 alveolar CO ppm + 0.26
Factor
Concentration ofcarbon monoxide in breathing atmosphere
Exposure duration
Respiratory ventilation
Blood volume
Barometric pressure
Diffusibility ofthe lungs from CO
Rate ofCO production (endogenous)
Exact ratio ofthe affinity ofblood for CO or02
ide. Whether carbonmonoxide, nicotine or tar are
the key factors in the relationship between ciga-
rette smoking and increased risk ofheart attack
has not been firmly established. However, impor-
tant clinical, experimental evidence, especially
by Aronow et al. (2), as well as many physiologi-
cal studies of carbon monoxide exposure and
myocardial metabolism and blood flow, certainly
suggests that carbon monoxide plays an impor-
tant, if not the primary, role in the relationship
between cigarette smoking and cardiovascular
disease. Furthermore, most evidence now sug-
gests that the predominant effect of cigarette
smokingisprobably relatedtothe acute onsetofa
heart attack rather than to the development of
underlying atherosclerosis. Cigarette smokers
living in countries in which the diet is low in
cholesterol and saturated fat do not generally
have extensive coronary atherosclerosis nor a
veryhighriskofheart attack (6). Individuals who
quit smokinghave a fairlyrapiddrop intheirrisk
of a heart attack (7). Both ofthese factors would
suggest that the effects of carbon monoxide or
cigarette smoking are probably on the acute pre-
cipitation ofa heart attack.
The importance of passive smoking, that is,
exposure to cigarette smoke produced by another
individual, in raising the carboxyhemoglobin lev-
els and increasing the risk ofdisease is a contro-
versial subject. Recent studies suggest that pas-
sive smoking could be an important source of
population exposure to carbon monoxide for non-
smokers and to disease especially in poorly venti-
lated areas (8). The recently reported startling
increase in lung cancer among nonsmokingwives
ofJapanese menwho smoke cigarettes couldhave
important implications ifverifiedbyfurther stud-
ies (9).
There are numerous occupational sources of
carbon monoxide. Michael (2) et al. recently com-
piled a long list ofjob titles associated with possi-
ble carbon monoxide exposures. There is solid
evidence that workers in certain occupations are
exposed to high carbon monoxide levels and ele-
vations ofcarboxyhemoglobin levels, especially if
they are also cigarette smokers (10). A study of
blast furnace workers, for example, has shown
that these men have carboxyhemoglobin levels
two to three times as high as among nonexposed
controls, and they also have a substantial in-
crease in their carboxyhemoglobin levels in the
blood from the beginning to the end oftheir work
shift (Table 4).
Nationwide estimates of carbon monoxide
emissions demonstrate a continuing downward
trend (Table 5) (1). This is primarily related to a
132CARBON MONOXIDE AND HEALTH
Table 4. Carboxyhemoglobin levels at the beginning and end ofa single shift related to smoking habits in blast
furnace and control groups (1962).a
COHb, % saturation
Beginning ofshift End ofshift
Use oftobacco Group No. in group Mean Range Mean Range
Nonsmokers Blast furnace 11 2.4 1.3-4.9 4.9 2.3-14.9
Control 21 1.3 0.8-2.1 1.5 0.9- 2.4
Usually <20 cigarettes/day Blast furnace 26 4.5 1.3-7.3 6.2 2.5-11.9
Control 24 3.1 0.9-6.6 3.2 1.1- 6.3
Usually >20 cigarettes/day Blast furnace 20 5.6 3.7-7.5 7.4 4.4-11.8
Control 18 3.7 2.0-5.5 4.0 2.2- 6.1
aData ofJones and Sinclair (10).
Table 5. Nationwide estimates ofcarbon monoxide emissions: 1940-75.a
Emissions, 106 metric tons/yr (109 kg/yr)b
Source category 1940 1950 1960 1968 1969 1970 1972 1975c
Thansportation 31.7 50.2 75.7 102.5 101.6 100.6 70.4 66.5
Industrial process losses 31.1 17.1 16.1 7.7 10.9 10.3 15.8 13.3
Agricultural burning 8.3 9.4 11.2 12.6 12.5 12.5 1.5 0.8
Fuel combustion in stationary sources 5.6 5.1 2.4 1.8 1.6 0.7 1.1 1.3
Solid-waste disposal 1.6 2.4 4.6 7.3 7.2 6.6 4.5 3.4
Miscellaneous 17.2 9.1 5.8 4.9 5.7 4.1 4.2 1.7
Tbtal 77.5 93.3 115.8 136.8 139.5 134.8 97.5 87.0
aNAS data.
bTb convert to U.S. short tons, multiply by 1.1 (1 short ton = 2 x 1031b).
cAnnual emission as ofMarch 12, 1975.
decrease in automobile exhaust emissions ofcar-
bon monoxide. The decrease in emissions is also
reflected in a decline in ambient carbon monoxide
levels in the community.
The importance of transport sources of carbon
monoxide has been previously evaluated by
studying the changes in carboxyhemoglobin and
expired air carbon monoxide among individuals
exposed to freeway traffic or heavy city conges-
tion. The Environmental Protection Agency esti-
mates that 42% of the U.S. population living on
2% ofthe U.S. land is reasonably heavily exposed
to carbon monoxide (>300 tons/mi2/yr).
A much better way ofdetermining carbon mon-
oxide exposure is by measuring blood carboxyhe-
moglobin levels. Several previous studies have
attempted to measure the distribution ofcarboxy-
hemoglobin levels among selected population
samples, such as blood donors or industrial work-
ers. These studies have also been limited by the
relatively crude method of estimating low levels
ofcarboxyhemoglobin.
Radford et al. (11) recently studied carboxyhe-
moglobin levels amongparticipants inthe Health
and Nutrition Survey II (Hanes II Study). Both
children and adults were included in the study.
Sensitive techniques were utilized for measuring
Table 6. Percent carboxyhemoglobin by season for
nonsmokers (cigarette).a
Carboxyhemoglobin,
Season Age %
Nov.-March 2-11 0.85
12-74 1.03
May-Sept. 2-11 0.58
12-74 0.70
aData ofRadford et al. (11).
carboxyhemoglobin levels and the sample is a
reasonable estimate ofthe U.S. population. Infor-
mation about cigarette smoking, residence and
season ofthe year were also collected. The levels
were measured for both children and adults. The
adult population was divided into those who
smoked and those who did not smoke. The levels
in the children and nonsmoking adults were rea-
sonably comparable (Table 6) (11). The higher
levels ofcarboxyhemoglobin in the winter as com-
pared to the spring or summer among nonsmok-
ers could reflect home heating sources (indoor air
pollution).
The carboxyhemoglobin levels were substan-
tiallyhigherforcigarette smokersthan nonsmok-
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ers. Approximately 80% ofcigarette smokers had
carboxyhemoglobin levels that were greater than
2%. Note, however, that 6.4% ofthe nonsmoking
population had carboxyhemoglobin levels greater
than 2% the goal ofthe ambient standard. There-
fore in the U.S. population there may be over
10,000,000 nonsmokers who have carboxyhemo-
globin levels above the goal ofthe ambient stan-
dards.
The carboxyhemoglobin levels were also corre-
lated with the degree ofurbanization among non-
cigarette smokers. However, the effects ofurban-
ization were relatively small as compared to that
due to cigarette smoking (11). The levels reported
by Radford are lower than those previously noted
(12). Differences in the methods of measurement
of carboxyhemoglobin, better delineation of
smokers from nonsmokers and differences in the
population sample may be factors which account
for these differences or possibly improvement in
air quality.
The health effects of carbon monoxide are de-
termined by several factors besides the carboxy-
hemoglobin levels (13). The major determinants,
however, are the carboxyhemoglobin levels in the
blood, duration of exposure, work effect and
health status. The last point is very critical since
high risk individuals are likely to be exposed to
pollution that may be detrimental to their health
butbe inconsequential forthe vast majority ofthe
population.
Fourtypesofstudieshave beendonethatrelate
levels ofcarbon monoxide to health, especially to
cardiovascular disease: community studies, clini-
cal experimental, occupational and animal lab-
oratory experimental studies.
The community studies are of the classical
type. The levels ofpollution, in this case ambient
carbon monoxide levels, are correlated with hos-
pital admissions, deaths or symptomatology. Usu-
allyno attempt hasbeenmade torelate the "dose"
of the pollutant to any specific individual or to
their disease. These "ecological" models have
been discussed in great detail (1). Earlier studies
have beendone in LosAngeles (14) andBaltimore
(15).
A more recent report from Denver included
emergency room visits for cardiovascular com-
plaints and ambient carbon monoxide levels (16).
Denver has high carbon monoxide levels, similar
to those in Los Angeles, and, because ofthe alti-
tude ofthe city and the lower partial pressure of
oxygen in the air, individuals are more likely to
have health effects related to these levels. The
visits to the emergency room related to carbon
monoxide levels both as a proportion of total
emergency room visits and as a daily frequency of
cardiovascular complaints. The correlations are
relatively weak but significant because of the
large number of days included in the anaylsis.
The one hour maximum ambient carbon monox-
ide levels for the high carbon monoxide days was
27.3 as compared to 12.1 for the low days. Other
pollutants apparently did not correlate with the
carbon monoxide levels inthe air. The interaction
ofweather changes, and possibly infections were
not included in the analysis.
Unlike other pollutants, the individual dose of
carbon monoxide can be measured in antimortem
or postmortem blood by determining the carboxy-
hemoglobin levels. A second type of community
study therefore has been to correlate carboxyhe-
moglobin levels either in living individuals or
among deaths usually due to cardiovascular dis-
ease with clinical or postmortem changes. A ma-
jor problem in these studies is the lag between
exposure and measurement and the need to ob-
tain a cigarette smoking history, as well as occu-
pational exposure. Studies of sudden death espe-
cially deaths which occur within moments to
individuals free of prior cardiovascular disease
present a possible sentinel of carbon monoxide
exposure relationship to heart attacks. About
20% ofall heart attacks fall intothis category and
represent an interesting population for study.
Furthermore, it is now possible by combining
carboxyhemoglobin measurements with thiocya-
nate to adjust to some degree for reported ciga-
rette smoking status.
Previous studies in Baltimore (15) and Los
Angeles (17) have analyzed postmortem blood
carboxyhemoglobin levels, among sudden deaths
due to arteriosclerotic heart disease and other
causes. The Baltimore study did not identify any
evidence of high levels of carboxyhemoglobin
among arteriosclerotic heart disease sudden
death that were previously non-cigarette smok-
ers. The Los Angeles study was also inconclusive.
The number of sudden deaths due to arterioscle-
rotic heart disease among nonsmokers was rela-
tively small and further expansion ofthese stud-
ies especially with more sensitive methods of
measuring carboxyhemoglobin and thiocyanate
levels as a marker of cigarette smoking may
enhance their utility in the future.
The occupational studies have either attempted
to measure the risk ofdeath among men exposed
to carbon monoxide or the prevalence of symp-
toms or specific electrocardiographic changes
among men occupationally exposed to carbon
monoxide. The extensive mortality follow-up
studies of steelworkers in the United States by
134CARBON MONOXIDE AND HEALTH
Redmond et al. (18) and the British blast furnace
studies (10) have both failed to identify any in-
creased risk ofcardiovascular disease. A study of
Finnish foundry workers also did not find any
excess cardiovascular mortality (19). Redmond
(20) tried to determine the relationship between
hot environments and cardiovascular mortality
within the steel industry. She did not measure
carbon monoxide levels in these areas but pre-
sumably they were correlated to some degree
with the hot environment. She did not find any
evidence of an increase risk of cardiovascular
mortality associated with a hot environment.
Several morbidity studies ofcardiovascular dis-
eases have been done. The British foundry work-
ers study did not identify any excess cardiovascu-
lar morbidity among the steelworkers as
compared to the general population in spite of
obvious increased carbon monoxide exposures
and high levels of carboxyhemoglobin present in
the workers (10). The Finnish foundry study com-
pared workers in high carbon monoxide expo-
sures and low in relationship to cardiovascular
morbidity (19). Of heavy carbon monoxide-ex-
posed nonsmoking furnace men and casters, 36%
had carboxyhemoglobin levels greater than 6%,
as did 71% ofthe occupationally exposed cigarette
smokers. There were no differences between the
exposed and nonexposed in electrocardiographic
changes, but exposed smokers or nonsmokers had
a higher prevalance of angina pectoris based on
the Rose Questionnaire than the nonexposed. The
exposed cigarette smokers had the highest preva-
lence ofangina pectoris.
The occupational studies have serious limita-
tions as currently designed because the highest
risk workers will often move out of the exposed
area because of symptomatology or health prob-
lems related to doing the type of work that is
necessary. The mortality studies include both
sudden and nonsudden deaths and do not sepa-
rate those men who have their heart attack on
thejob from those that have a heart attack offthe
job. Since the carbon monoxide exposures may be
acute precipitating events for heart attack, it
would probably be more advisable to study the
distributions of heart attacks on the job in rela-
tionship to carbon monoxide exposure, and per-
haps carboxyhemoglobin levels. It also would be
necessary to separate first heart attack deaths
from individuals who die subsequent to a heart
attack years after they have left thejob. Also the
attributable risks due to carbon monoxide expo-
sure may be extremely low in comparison to
smoking, blood pressure, cholesterol, etc., and
difficult to identify in large population samples.
Future occupational studies will have to have a
more efficient design ifthe potential carbon mon-
oxide exposures and cardiovascular morbidity
and mortality are to be evaluated.
The clinical, experimental studies have pro-
vided the richest source ofinformation about the
relationship between low dose carbon monoxide
exposure and heart disease (Table 7). Many of
these studies have been previously reviewed.
In the classical study, high risk individuals,
usually with angina pectoris, are exposed to a
dose of carbon monoxide that will raise the car-
boxyhemoglobin level to some predetermined
level, such as 2% to 4% carboxyhemoglobin. The
men are thenexercise testedon either abicycle or
treadmill and their responses evaluated. The end
point was usually time ofsymptomatology, prod-
uct of systolic blood pressure and pulse at the
time of symptoms and ECG changes especially
ST-T waves. Most ofthe recent studies have been
double blinded.
Aronow has studied men with angina pectoris
(2), intermittent claudication (21), and chronic
obstructive pulmonary disease (22) (Table 8). Ad-
verse health effects have been noted with car-
boxyhemoglobin levels as low as 2%. This method
is clearly very sensitive to the study of low dose
carboxyhemoglobin levels. However, the ap-
proach is different from the type of exposure in
the general population since the carboxyhemoglo-
bin levels are established by breathing relatively
high concentrations of carbon monoxide (i.e., 50
ppm for 1 hr) in order to reach the desired car-
boxyhemoglobin level in the blood rather than
relatively low dose exposure to carbon monoxide
for longer periods oftime. The importance ofthis
difference in exposure, however, is undetermined.
Aronow has also attempted to use this model to
study behavioral effects. The studies have been
inconclusive (23).
Davies and Smith (24) recently completed an
important study of low dose carbon monoxide
exposure and electrocardiographic changes
among healthy nonsmokingyoung men (Table 9).
Six groups of healthy, nonsmoking young men
lived in a closed environmental exposure cham-
ber for 18 days (Table 9). During the middle 8
days they were exposed to 50, 15 or 0 (control)
ppm ofcarbon monoxide. P-wave changes on the
electrocardiogram were seen in 6 of15 subjects at
50 ppm and 3 of 15 at 15 ppm, but in none ofthe
controls. It was possible that the P-wave changes
may represent a toxic effect of carbon monoxide
on atrial pacing and conduction tissue.
These studies more closely respond to the true
environmental studies. The effects in normal
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Table 7. Recent clinical and animal experimental studies ofthe relationship between carbon monoxide and disease.
Study
4% Carboxyhemoglobin on
human performance in
cardiac patients
Effect ofnonnicotine cigarettes
and CO on angina
Aggravation ofangina pectoris
by 2% carboxyhemoglobin
Effect ofpassive smoking on
angina pectoris
Electrocardiographic changes in
healthy men during
continuous low-level carbon
monoxide exposure
Angina pectoris, ECG findings
and BP offoundry workers in
relation to CO exposure
Methods
Double-blinded crossover study,
20 men with angina pectoris,
COHb to 3.9%
Double-blinded crossover, 12
men, COHb to 5.35%
Double-blinded, randomized,
crossover study, 15 men 50
ppm CO, 1 hr raise COHb to
2.02%
Ten patients with angina
exposed to 15 cigarette
smokers within 2 hr in a
well-ventilated room or
unventilated room;
well-ventilated room COHb to
1.77, unventilated to 2.28
Six groups ofhealthy young
men living in a
closed-environment exposure
chamber for 18 days; exposed
to 50, 15 or 0 ppm CO
Prevalence study in foundry in
relation to CO exposure
Results
Significant impairment of
visualization test after
breathing CO
Decreased exercise time to
angina > ST-segment
depression: decreased systolic
BP x heart rate at angina
worse for smokers
Decrease exercise to angina;
decrease in systolic BP x
heart rate at time ofangina
Passive smoking caused angina
to develop sooner; worse in
unventilated room; increased
systolic BP and heart rate at
angina
P-wave changes on ECG at both
50 and 15 ppm ofCO
Higher prevalence ofpossible
angina history but not ECG
changes with greater CO
exposure
Table 8. Mean carboxyhemoglobin levels in three population studies (nonsmokers).
Study Mean % >1.5 Reference
St. Louis (1974) (31)
Industrial workers 1.38 ± 0.040
Nonindustrial workers 0.75 ± 0.013
Nationwide survey (1974) (blood donors) (12)
Los Angeles 1.8 76
Chicago 1.7 74
Vermont 1.2 18
Denver 2.0 76
HANES II (11)
Never smokers 0.87 ± 0.74 08
Center citya 1.10 ± 0.59 16
Not center citya 0.97 + 0.78 12
Rurala 0.76 ± 0.63 05
aWhite adults only.
young individuals are surprising and a possible
cause for concern. They clearly need to be repli-
cated, as well as similar studies, using high risk
individuals.
The recent animal experimental studies have
either attempted to determine the role ofcarbon
monoxide in promoting the development ofather-
osclerosis or on lipoprotein metabolism or the
effects ofcarbon monoxide on ventricular fibrilla-
tion threshold. The atherogenesis studies are con-
flicting but carbon monoxide exposure may in-
crease atherogenesis in the presence of a high fat
orcholesterol diet in a susceptible individual (25).
Table 9. Electrocardiographic changes in healthy men
during continuous low level carbon monoxide
exposure.a
Mean CO level No. showing
during exposure No. of ECG changes
CO run period, ppm subjects during exposure
I (pilot) 75 10 7
II 50 9 4
III 0 (control) 8 0
IV 15 9 3
V 0 (control) 6 0
VI 50 6 2
VII 15 7 1
aData ofDavies and Smith (24).
Reference
(23)
(23)
(23)
(8)
(24)
(19)
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Several studies have shown that relatively high
levels of carbon monoxide usually around 100
ppm decrease the ventricular fibrillation thres-
hold in both the dog and primate (Table 10) (26).
This essentially means that a lower electrical
shock for a shorter period of time will result in
ventricular fibrillation in the presence of carbon
monoxide. Studies have also shown that the
threshold is lowered both in normal animals and
those with a previously induced myocardial in-
farction (27). These studies are attempting to
replicate the experience ofsudden death in man.
The availability of large numbers of individuals
monitored by mobile coronary care units outside
of the hospital may make it possible to do more
extensive studiesofthe relationship between ven-
tricular fibrillation, sudden death and environ-
mental carbon monoxide exposures.
The carbon monoxide standard has not been
based on possible health effects to the fetus and
newborn. Previous animal experimental and hu-
man pathology studies have described an appar-
ent effect ofcarbon monoxide on fetal growth and
placental pathology (1). Epidemiological studies
have determined that women who smoke during
pregnancy have babies with low birth weights,
increased perinatal mortality and certain compli-
cations ofpregnancy and delivery (28). The spe-
cific effects of carbon monoxide independent of
other products of cigarette smoke have not been
determined. An increasing number ofwomen are
employed during their pregnancy. The possibility
that women, both cigarette smokers and non-
smokers, may be exposed to an increased risk of
low birth weight babies, higher perinatal mortal-
ity and complications due to exposure to carbon
monoxide even at low dose must be considered.
Studies to evaluate this potential risk, however,
will be very difficult to design.
Discussion
There is little evidence to suggest that the
current carbon monoxide standard is too high.
The more critical question now relates towhether
the clinical-experimental studies can be related
to any substantial health risk in the population.
The key determinants of whether current am-
bient carbon monoxide levels are hazardous re-
late to the size of the population at risk, the
exposure dose and the excess risk per increased
dose. There is no way at the present time of
determining the exact increased risk associated
with any specific level ofcarboxyhemoglobin. We
can-only accept the fact that 2% carboxyhemoglo-
bin is associated with an apparent increased
Table 10. Recent animal experimental studies ofthe
relationship between carbon monoxide and disease.
Study Methods and results Reference
Effects ofcarbon mon- Exposure to 100 ppm (26)
oxide inhalation on C0 9.3% increase in
ventricular fibrilla- COHb
tion in monkeys Ventricular fibrilla-
tion threshold in-
creases in both in-
farcted and normal
monkeys
Carbon monoxide and 100 ppm CO for 2 hr (27)
ventricular fibrilla- Increase,COHb 6.48%
tion threshold in Decrease ventricular
normal dogs fibrillation threshold
symptomatology amongpatientswithanginapec-
toris. Whether this can be translated into an
increased risk of heart attack and sudden death
has not been adequately determined. Only one
study has determined that relatively low doses of
carbon monoxide are associated with possible
changes in the electrocardiogram in normal indi-
viduals which might relate to cardiovascular dis-
ease (24). The results reported in that study, that
is, the P-wave changes, mustbefurtherevaluated
prior to their use as part ofthe carbon monoxide
standard setting activities. The most important
population at risk are probably individuals with
clinical heart disease, chronic obstructive pulmo-
nary disease and intermittent claudication.
Datadescribingthe prevalence ofheart disease
in the community is surprisingly difficult to ob-
tain. The National Health Interview Survey in
1973 provided information about the prevalence
ofheart disease 13.6/1000 (29), and chronic bron-
chitis, 32.7/1000 (30). These are probably under-
estimates, since they are based on interview only
andnotonphysicalexamination. Still,however, a
substantial percentage ofthe United States popu-
lationhas either aknown history ofheartdisease
or chronic obstructive pulmonary disease and
would be considered at high risk for low dose
carbon monoxide effect.
The percentage of the population overall ex-
posed to carbon monoxide levels which result in
carboxyhemoglobin levels above 1.5 to 2% has
fallen if one compares the data from previous
studies and that of the Hanes II report, as pro-
vided by Radford (Table 9). As previously men-
tioned,thereasonsforthedifferences inthelevels
reported by these studies may not only be due to
decreases in air pollution but also to sampling
and methods of measuring carboxyhemoglobin.
However, even using the data from Radford's
study, a substantial portion of the U.S. adult
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population, probably over 10 million, is exposed
to potentially deleterious levels ofcarbon monox-
ide. Presuming that 75% of patients with coro-
nary heart disease are nonsmokers and that the
prevalence of coronary heart disease among
adults is about 20/1000 would result in approxi-
mately 170,000 persons with heart disease who
are nonsmokers and might have major effects
from low dose environmental carbon monoxide
exposures. The cigarette smokers obviously
would also be exposed since the ambient carbon
monoxide level would enhance the cigarette
smoking effects. Furthermore, ifwe presume that
20-30% of all patients with heart disease have
major coronary artery disease symptomatology
that will increase their risk of heart attack and
sudden death, then there may be 35,000-50,000
people at high risk. Ifwe were to further presume
thattheirrisk ofdeath was about 5% peryear and
that carbon monoxide exposure doubled the risk,
then perhaps 1250 excess deaths related to low
dose environmental carbon monoxide exposure in
this population might be noted each year in the
United States. This analysis is obviously crude
and excludes many individuals who have severe
coronary artery disease, were asymptomatic and
may die suddenly when exposed to carbon monox-
ide, patients with chronic obstructive pulmonary
disease who also apparently are at increased risk
orthe large number ofpregnantwomen each year
who may have increased perinatal mortality and
low birth weight babies.
There is clearly a need to determine whether
the increased risks noted by these clinical, epide-
miological and animal experimental studies can
be translated into true risks in the community.
These studies should primarily be aimed at high
risk populations such as occupationally exposed
groups to high levels ofcarbon monoxide, groups
at high risks due to disease such as patients with
heart disease and chronic obstructive pulmonary
disease and pregnant women.
The monitoring ofcarbon monoxide in the com-
munity should depend primarily on the measure-
ment of carboxyhemoglobin levels and not on
ambient carbon monoxide monitoring in the com-
munity. The clinical laboratory studies previ-
ously done by Aronow et al. should be replicated
in other laboratories with longer exposures at
lower doses of carbon monoxide and with more
subjects per experiment. The interesting long-
term chamber studies must be replicated (24). If
the results of those studies can be validated by
other investigators, then the importance of low
dose carbon monoxide exposures may be much
greater than anticipated.
Finally, it should be recognized that the major
source of carbon monoxide in the population is
cigarette smoking. The effects of low-dose am-
bient carbon monoxide exposures from all other
sources onthe health ofthe population is minimal
compared to the effects of cigarette smoking.
Thus, reduction ofcigarette smoking in the popu-
lation should certainly remain the highest public
health priority.
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